ELAPRASE
idursulfase
Listed by Takeda Pharmaceuticals America, Inc.
- Strength
- 6 mg/3mL
- Form
- Solution, Concentrate
- Route
- Intravenous
- Class
- Hydrolytic Lysosomal Glycosaminoglycan-specif…
What it contains
- Idursulfase 6 mg/3mL
FDA record
| Dosage form | Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Approval route | BLA — biologic licence |
| NDC code | 54092-700 |
| FDA application | BLA125151 |
| RxNorm concept | 644104 |
| Package sizes listed | 1 |
| Marketed since | July 2006 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.